ArticleInternal medicine (Tokyo, Japan)2026

Fulminant Type 1 Diabetes Induced by Immune Checkpoint Inhibitors in a Patient with Autoimmune Predisposition.

Miyu Tomiki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.